View Document Preview and Link Document Date: 2001-02-01 13:29:24 Open Document File Size: 341,31 KB Share Result on Facebook
City Dallas / Lausanne / Stroke / / Company Future Developments In / C5 / LG / Novartis / Gazdick LP / Telmisartan Blood Pressure Monitoring Group / American Heart Association Inc. / Bain / Merck / Sanofi / Diabetics / Ribeiro AB / Shimizu / AstraZeneca / Bristol Myers Squibb / / Country Switzerland / Norway / United States / / / Event FDA Phase / Reorganization / / Facility Weir MR / / IndustryTerm online version / treatment of congestive cardiac failure / end product / Food decreases drug absorption / hydroxymethyl / food products / food / food effect / treatment of high blood pressure / treatment of congestive heart failure / treatment of hypertension / treatment of chronic renal diseases / / MedicalCondition renal artery stenosis / In heart failure / insulin-dependent diabetes mellitus / JE / Feenstra J. Angioneurotic edema / diabetes MI / left ventricular dysfunction / renal diseases / symptomatic heart failure / Vasodilator Heart Failure Trial / chronic renal failure / Essential hypertension / tubular necrosis / systemic hypertension / neuroblastoma cell lines / experimental cardiac hypertrophy / low blood pressure / renal fibrosis / vascular injury / postrenal transplant erythrocytosis / mildto-moderate hypertension / chronic congestive heart failure / glomerular injury / end-stage renal disease / renal dysfunction / congestive cardiac failure / renal injury / II diabetes / hypotension / Acute Myocardial Infarction / severe heart failure / proteinuria / mild-to-moderate hypertension / severe renal dysfunction / congestive heart failure / diabetic nephropathy / hypertension / refractory congestive heart failure / tissues AT3 Unknown Neuroblastoma / left ventricular hypertrophy / Chronic / ESRD / stroke / diastolic dysfunction / Heart Failure Trial / human IgA nephropathy / Cardiovascular mortality Stroke / severe hypertension / IgA nephropathy / myocardial infarction / chronic renal diseases / very slow dissociation / heart failure / heart attack / angioedema / diseases / vascular and cardiac fibrosis / rebound hypertension / posttransplant erythrocytosis / high blood pressure / high-renin hypertension / cough / severe congestive heart failure / severe primary hypertension / acute renal failure / / MedicalTreatment combination drug therapy / drug therapy / / Organization Editorial Office / Oral administration / Copyright Clearance Center / US Food and Drug Administration / American Heart Association / Division of Hypertension and Vascular Medicine / / Person Ann Int Med / M. Burnier / Arch Intern / Van Rijnsoever / / Position Gansevoort RT / Smith WB / et al / Cao / / Product Valsartan / Irbesartan / EXP / nifedipine / indomethacin / losartan / Telmisartan / ramipril / ELITE / lisinopril / digoxin / acetic acid / Candesartan cilexetil / lisinopril and hydrochlorothiazide / captopril / losartan potassium / felodipine / AT4 Renal / enalapril maleate / atenolol / hydrochlorothiazide / AT1 / / ProvinceOrState Texas / / Technology Cloning / apoptosis / Pharmacokinetics / / URL http / SocialTag 
Cardiovascular Drugs Angiotensin II Type 1 Receptor Blockers Michel Burnier, MD I